217 related articles for article (PubMed ID: 29766807)
1. First Total Synthesis of ω-Phenyl Δ6 Fatty Acids and their Leishmanicidal and Anticancer Properties.
Carballeira NM; Morales-Guzman C; Alvarez-Benedicto E; Torres-Martinez Z; Delgado Y; Griebenow KH; Tinoco AD; Reguera RM; Perez-Pertejo Y; Carbajo-Andres R; Balana-Fouce R
Curr Top Med Chem; 2018; 18(5):418-427. PubMed ID: 29766807
[TBL] [Abstract][Full Text] [Related]
2. 2-Alkynoic fatty acids inhibit topoisomerase IB from Leishmania donovani.
Carballeira NM; Cartagena M; Sanabria D; Tasdemir D; Prada CF; Reguera RM; Balaña-Fouce R
Bioorg Med Chem Lett; 2012 Oct; 22(19):6185-9. PubMed ID: 22932312
[TBL] [Abstract][Full Text] [Related]
3. Substituted 1,5-naphthyridine derivatives as novel antileishmanial agents. Synthesis and biological evaluation.
Tejería A; Pérez-Pertejo Y; Reguera RM; Balaña-Fouce R; Alonso C; González M; Rubiales G; Palacios F
Eur J Med Chem; 2018 May; 152():137-147. PubMed ID: 29704722
[TBL] [Abstract][Full Text] [Related]
4. Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect.
Prada CF; Alvarez-Velilla R; Balaña-Fouce R; Prieto C; Calvo-Álvarez E; Escudero-Martínez JM; Requena JM; Ordóñez C; Desideri A; Pérez-Pertejo Y; Reguera RM
Biochem Pharmacol; 2013 May; 85(10):1433-40. PubMed ID: 23466420
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of marine α-methoxylated fatty acid analogs that effectively inhibit the topoisomerase IB from Leishmania donovani with a mechanism different from that of camptothecin.
Carballeira NM; Montano N; Alvarez-Velilla R; Prada CF; Reguera RM; Balaña-Fouce R
Mar Drugs; 2013 Sep; 11(10):3661-75. PubMed ID: 24084785
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of piperazinyl-β-carbolinederivatives as anti-leishmanial agents.
Ashok P; Chander S; Smith TK; Sankaranarayanan M
Eur J Med Chem; 2018 Apr; 150():559-566. PubMed ID: 29549840
[TBL] [Abstract][Full Text] [Related]
7. Antileishmanial effect of new indeno-1,5-naphthyridines, selective inhibitors of Leishmania infantum type IB DNA topoisomerase.
Tejería A; Pérez-Pertejo Y; Reguera RM; Balaña-Fouce R; Alonso C; Fuertes M; González M; Rubiales G; Palacios F
Eur J Med Chem; 2016 Nov; 124():740-749. PubMed ID: 27639365
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives.
Dea-Ayuela MA; Bilbao-Ramos P; Bolás-Fernández F; González-Cardenete MA
Eur J Med Chem; 2016 Oct; 121():445-450. PubMed ID: 27318121
[TBL] [Abstract][Full Text] [Related]
9. Antileishmanial activity evaluation of bis-lawsone analogs and DNA topoisomerase-I inhibition studies.
Sharma G; Chowdhury S; Sinha S; Majumder HK; Kumar SV
J Enzyme Inhib Med Chem; 2014 Apr; 29(2):185-9. PubMed ID: 23534930
[TBL] [Abstract][Full Text] [Related]
10. A Novel Spirooxindole Derivative Inhibits the Growth of Leishmania donovani Parasites both In Vitro and In Vivo by Targeting Type IB Topoisomerase.
Saha S; Acharya C; Pal U; Chowdhury SR; Sarkar K; Maiti NC; Jaisankar P; Majumder HK
Antimicrob Agents Chemother; 2016 Oct; 60(10):6281-93. PubMed ID: 27503653
[TBL] [Abstract][Full Text] [Related]
11. Discovery of new organoselenium compounds as antileishmanial agents.
Al-Tamimi AS; Etxebeste-Mitxeltorena M; Sanmartín C; Jiménez-Ruiz A; Syrjänen L; Parkkila S; Selleri S; Carta F; Angeli A; Supuran CT
Bioorg Chem; 2019 May; 86():339-345. PubMed ID: 30743174
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Leishmania donovani topoisomerase IB selective inhibitors by targeting protein-protein interactions between the large and small subunits.
Lee H; Baek KH; Phan TN; Park IS; Lee S; Kim J; No JH
Biochem Biophys Res Commun; 2021 Sep; 569():193-198. PubMed ID: 34256188
[TBL] [Abstract][Full Text] [Related]
13. Novel diindoloazepinone derivatives as DNA minor groove binding agents with selective topoisomerase I inhibition: Design, synthesis, biological evaluation and docking studies.
Kadagathur M; Devi GP; Grewal P; Sigalapalli DK; Makhal PN; Banerjee UC; Bathini NB; Tangellamudi ND
Bioorg Chem; 2020 Jun; 99():103629. PubMed ID: 32272367
[TBL] [Abstract][Full Text] [Related]
14. Novel Hybrid Molecules on the Basis of Steroids and (5Z,9Z)-Tetradeca-5,9-dienoic Acid: Synthesis, Anti-Cancer Studies and Human Topoisomerase I Inhibitory Activity.
D'yakonov VA; Dzhemileva LU; Tuktarova RA; Ishmukhametova SR; Yunusbaeva MM; Ramazanova IR; Dzhemilev UM
Anticancer Agents Med Chem; 2017; 17(8):1126-1135. PubMed ID: 27928953
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II.
Zhuo ST; Li CY; Hu MH; Chen SB; Yao PF; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS
Org Biomol Chem; 2013 Jun; 11(24):3989-4005. PubMed ID: 23657605
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.
Zhang X; Wang R; Zhao L; Lu N; Wang J; You Q; Li Z; Guo Q
Bioorg Med Chem Lett; 2012 Jan; 22(2):1276-81. PubMed ID: 22079759
[TBL] [Abstract][Full Text] [Related]
17. 4-Arylamino-6-nitroquinazolines: Synthesis and their activities against neglected disease leishmaniasis.
Saad SM; Ghouri N; Perveen S; Khan KM; Choudhary MI
Eur J Med Chem; 2016 Jan; 108():13-20. PubMed ID: 26619389
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Molecular Docking and Biological Evaluation of Quinolone Derivatives as Novel Anticancer Agents.
Li J; Zheng TC; Jin Y; Xu JG; Yu JG; Lv YW
Chem Pharm Bull (Tokyo); 2018 Jan; 66(1):55-60. PubMed ID: 29118308
[TBL] [Abstract][Full Text] [Related]
19. Drug-like molecules with anti-trypanothione synthetase activity identified by high throughput screening.
Benítez D; Franco J; Sardi F; Leyva A; Durán R; Choi G; Yang G; Kim T; Kim N; Heo J; Kim K; Lee H; Choi I; Radu C; Shum D; No JH; Comini MA
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):912-929. PubMed ID: 35306933
[TBL] [Abstract][Full Text] [Related]
20. Novel gold(I) complexes with 5-phenyl-1,3,4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents.
Chaves JDS; Tunes LG; de J Franco CH; Francisco TM; Corrêa CC; Murta SMF; Monte-Neto RL; Silva H; Fontes APS; de Almeida MV
Eur J Med Chem; 2017 Feb; 127():727-739. PubMed ID: 27823888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]